Report Overview:
Capillary blood collection lancets are medical devices designed to obtain small blood samples for diagnostic testing. These lancets are widely used in hospitals, clinics, and homecare settings by patients suffering from cardiovascular and endocrine disorders, such as diabetes. The device consists of a sharp, single-use needle encased in a plastic or metal body to ensure minimal discomfort and safe disposal after use.
Market Value:
The global Capillary Blood Collection Lancet market was valued at USD 1857 million in 2024 and is projected to reach USD 2905.60 million by 2032, reflecting a CAGR of 5.10%. The growing prevalence of diabetes and the increasing adoption of home-based glucose monitoring devices are key contributors to market expansion.
CAGR of 5.10% (2025 – 2032)
By Types:
• Safety Lancets
• Ordinary Lancets
By Applications:
Hospitals & Clinics
Home Use
Key players include:
• Cardinal Health
• ARKRAY
• ICU Medical
• Owen Mumford
• HemoCue
• Greiner Bio One
• Including or Excluding key companies relevant to your analysis.
